|
|
|
|
|
Teisho pharmaceutical 
|
|
Taisho Pharmaceutical Co Ltd was founded on 12th October 1912 and was established only on 5th of May 1928 at Bunkyo Ward
|
|
|
|
|
|
|
|
|
|
|
|
| Latest News About taisho pharmaceutical |
|
|
Andhellip; and Comarketingabkommen with Taisho... - Japan Betriebsnachrichten - Japan Betriebsnachrichten...
Subscription - Wall Street Journal Online - Dow-Jones and firm - On the 17th Sep, 2001
A Tanabe Seiyaku share becomes 0.55 Taisho pharmaceutical share under same... Akira Uehara, president of Taisho pharmaceutical, will become president of....More |
|
|
|
|
Co Ltd pharmaceutical Taisho. n/on. Pherin has signs pharmaceutical and pharmaceutical Taisho a research and option agreement to disk..More |
|
|
|
|
Co. pharmaceutical Taisho, Ltd., headquartered in Tokyo, the uppermost pharmaceutical firm is in over-that-meter health care products in Japan and sets to away....More |
|
|
|
|
Co pharmaceutical 2727.8,4.3,35 Taisho. 2596.7,18.7,36 Novo Nordisk AS a 2993.4,16.8,37 Nycomed Amersham Plc. Co pharmaceutical 2056.4,13.9,38 Chugai. ....More |
|
|
|
|
Tokyo, on the 8 July, 2004 (JCN) - Taisho pharmaceutical (TSE: 4535) announced on the 6 July that it had carried out successfully a zero of from currents, plan at its Hanyu...More |
|
|
|
|
Co pharmaceutical 13.5,25 Altana CORP. 13.4,26 Taisho. 13.2,27 Procter and speculates Co. 12.7,28 Astellas pharmaceuticals inc. 11.8,29 Schering CORP. 11.7,30 Shionogi and Co. ....More |
|
|
|
|
Taisho is a pharmaceutical firm. It was established in October 12, 1912 dutiful to the pursuit of... Co Ltd pharmaceutical impending milestones for Taisho. ....More |
|
|
|
|
Co. pharmaceutical Taisho, is Ltd. the leading firm in the Asia-Pacific OTC. pharmaceutical market. This firm has total incomes of $2.7 billions erzeugt...More |
|
|
|
|
Co pharmaceutical 2239.8,37,38 Taisho. Ltd. Co pharmaceutical Tokyo 2097.1,38,33 Daiichi. Ltd. Tokyo 2091.5,39,40 Synthelabo Le Plessis Robinson Cedex,....More |
|
|
|
|
Can 15, the Taisho of Co. 2003 pharmaceutical, decided Ltd. to interrupt thedevelopment of. EPI-2010 to become a drug for asthma developed collective with EpiGenesis....More |
|
|
|
|
|
|
|
